• SCIENTIFIC HIGHLIGHTS

Discovery of Potent EGFR Inhibitors through the Incorporation of a 3D-Aromatic-Boron-Rich-Cluster into the 4-Anilinoquinazoline Scaffold: Potential Drugs for Glioma Treatment

Marcos Couto, María Fernanda García, Catalina Alamón, Prof. Mauricio Cabrera, Prof. Pablo Cabral, Prof. Alicia Merlino, Prof. Francesc Teixidor, Prof. Hugo Cerecetto, Prof. Clara Viñas. Chem. Eur. J. doi:10.1002/chem.201705181

Cover ChemAEurJournal 2New 1,7-closo-carboranylanilinoquinazoline hybrids have been identified as EGFR inhibitors, one of them with higher affinity than the parent compound erlotinib. The comparative docking analysis with compounds bearing bioisoster-substructures, demonstrated the relevance of the 3D aromatic-boron-rich moiety for interacting into the EGFR ATP binding region. The capability to accumulate in glioma cells, the ability to cross the blood–brain barrier and the stability on simulated biological conditions, render these molecules as lead compounds for further structural modifications to obtain dual action drugs to treat glioblastoma.

 

Related Topics: Cover, Biomaterials and materials for drug delivery, therapy, diagnostics and sensing

Also on ICMAB...

Search

Your experience on this site will be improved by allowing cookies Cookie Settings